Skip to main content

Table 2 Effects of increasing dietary fibre intakes on cardiometabolic risk factors in patients with established CVD

From: Dietary fibre in hypertension and cardiovascular disease management: systematic review and meta-analyses

Outcome

Trials

Participants (I/C)

Initial I2

MD (95% CI)

Grade

Total cholesterol (mmol/L)

3

117/110

99%

− 0.42 (− 0.78 to − 0.05)

Low

LDL cholesterol (mmol/L)

3

117/110

99%

− 0.47 (− 0.85 to − 0.10)

Low

HDL cholesterol (mmol/L)

3

117/110

99%

0.08 (− 0.02 to 0.17)

Low

Triglycerides (mmol/L)

3

117/110

91%

− 0.03 (− 0.15 to 0.08)

Low

Systolic blood pressure (mmHg)

1

38/38

-

− 1.2 (− 2.0 to − 0.4)

Very low

Diastolic blood pressure (mmHg)

1

38/38

-

− 3.6 (− 4.0 to − 3.2)

Very low

Body weight (kg)

1

61/53

-

− 0.20 (− 0.37 to − 0.04)

Very low

BMI (kg/m2)

2

99/91

98%

− 0.30 (− 0.69 to 0.09)

Low

Waist circumference (cm)

1

61/53

-

− 0.5 (− 0.6 to − 0.4)

Very low

Fasting plasma glucose (mmol/L)

2

99/91

100%

− 1.23 (− 2.13 to − 0.33)

Low

Fasting plasma insulin (pmol/L)

1

38/38

-

− 10.8 (− 13.2 to − 8.4)

Very low